A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol

Anshika Jain,Ryan Huang,Jasmine Lee,Natasha A. Jawa,Yong Jin Lim,Mike Guron,Sharon Abish,Paul C. Boutros,Michael Brudno,Bruce Carleton,Geoffrey D.E. Cuvelier,Lakshman Gunaratnam,Cheryl Ho,Khosrow Adeli,Sara Kuruvilla,Giles Lajoie,Geoffrey Liu,Paul C. Nathan,Shahrad Rod Rassekh,Michael J. Rieder,Sushrut S. Waikar,Stephen Welch,Matthew A. Weir,Eric Winquist,David S. Wishart,Alexandra P. Zorzi,Tom Blydt-Hansen,Michael Zappitelli,Bradley L. Urquhart

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol

2021

Background:Cisplatin, a chemotherapy used to treat solid tumors, causes acute kidney injury (AKI), a known risk factor for chronic kidney disease and mortality. AKI diagnosis relies on biomarkers w...

Keywords:

Cisplatin
Nephrotoxicity
Medicine
protocol
Oncology
Internal medicine
Clinical research
accent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations